iKang Healthcare Group (NASDAQ:KANG) was downgraded by BidaskClub from a “buy” rating to a “hold” rating in a report released on Thursday.
KANG stock traded down $0.01 during mid-day trading on Thursday, reaching $20.53. The company’s stock had a trading volume of 45,902 shares, compared to its average volume of 161,738. The company has a market cap of $1.42 billion, a P/E ratio of 88.91 and a beta of -0.13. The company has a debt-to-equity ratio of 0.08, a quick ratio of 0.69 and a current ratio of 0.71. iKang Healthcare Group has a 12 month low of $15.27 and a 12 month high of $21.01.
iKang Healthcare Group (NASDAQ:KANG) last issued its earnings results on Thursday, December 20th. The medical research company reported $0.23 earnings per share for the quarter. The business had revenue of $177.69 million during the quarter. iKang Healthcare Group had a positive return on equity of 4.25% and a negative net margin of 2.88%.
Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Jane Street Group LLC bought a new stake in shares of iKang Healthcare Group during the second quarter valued at approximately $226,000. Bank of Montreal Can bought a new stake in shares of iKang Healthcare Group during the third quarter valued at approximately $268,000. BlackRock Inc. increased its holdings in shares of iKang Healthcare Group by 8.5% during the second quarter. BlackRock Inc. now owns 959,409 shares of the medical research company’s stock valued at $19,630,000 after acquiring an additional 75,480 shares in the last quarter. Alpine Associates Management Inc. bought a new stake in shares of iKang Healthcare Group during the third quarter valued at approximately $1,497,000. Finally, Natixis bought a new stake in shares of iKang Healthcare Group during the second quarter valued at approximately $2,048,000. Hedge funds and other institutional investors own 38.23% of the company’s stock.
iKang Healthcare Group Company Profile
iKang Healthcare Group, Inc, together with its subsidiaries, provides preventive healthcare solutions in the People's Republic of China. It operates in two segments, Medical Examinations, and Other Medical Services and Dental Services. The company offers a range of medical examinations, including internal, gynecology, ophthalmology, ENT, dental, lab test, electrocardiogram, ultrasound, and X-ray examination items.
Featured Article: Google Finance Portfolio Tips and Tricks
Receive News & Ratings for iKang Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iKang Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.